or Try an Advanced Search...

    Technical Analysis for TYP - Tryptamine Therapeutics Limited

    Grade Last Price % Change Price Change
    B 0.045 -4.26% -0.002
    TYP closed down 4.26 percent on Thursday, November 21, 2024, on approximately normal volume.
    Earnings due: Nov 22
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong N/A Up Down
    Historical TYP trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Wide Bands Range Expansion -4.26%
    Calm After Storm Range Contraction -6.25%
    Doji - Bullish? Reversal -6.25%
    Wide Bands Range Expansion -6.25%
    Calm After Storm Range Contraction -4.26%
    NR7 Range Contraction -4.26%
    Narrow Range Bar Range Contraction -4.26%
    Inside Day Range Contraction -4.26%
    Older End-of-Day Signals for TYP ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 6 hours ago
    Gap Up Closed about 9 hours ago
    Gap Up Partially Closed about 9 hours ago
    Reversed from Up about 9 hours ago
    Fell Below Previous Day's Low about 9 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    TYP Chart by TradingView
    Basic chart:

    Profile

    Tryp Therapeutics Inc., a clinical-stage pharmaceutical development company, focuses on developing psilocybin-related molecules in Canada and the United States. Its lead program candidate TRP-8803, a proprietary formulation of IV-infused psilocin that completed Phase 2a clinical trial for the treatment of binge eating disorder, fibromyalgia, abdominal pain, and visceral tenderness. The company's program candidate TRP-8802, a synthetic and oral psilocybin for the treatment of binge eating, chronic pain, and other indications. The company was formerly known as Artos Pharma Corp. and changed its name to Tryp Therapeutics Inc. in June 2020. Tryp Therapeutics Inc. was incorporated in 2019 and is based in Kelowna, Canada.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pharmaceutical Development

    Is TYP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.057
    52 Week Low 0.017
    Average Volume 4,003,774
    200-Day Moving Average 0.000
    50-Day Moving Average 0.027
    20-Day Moving Average 0.039
    10-Day Moving Average 0.047
    Average True Range 0.004
    RSI (14) 61.69
    ADX 53.11
    +DI 35.159
    -DI 11.661
    Chandelier Exit (Long, 3 ATRs) 0.045
    Chandelier Exit (Short, 3 ATRs) 0.031
    Upper Bollinger Bands 0.059
    Lower Bollinger Band 0.019
    Percent B (%b) 0.66
    BandWidth 102.577
    MACD Line 0.007
    MACD Signal Line 0.007
    MACD Histogram 0.0001
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.050
    Resistance 3 (R3) 0.050 0.049 0.049
    Resistance 2 (R2) 0.049 0.048 0.049 0.048
    Resistance 1 (R1) 0.047 0.047 0.047 0.047 0.048
    Pivot Point 0.046 0.046 0.046 0.046 0.046
    Support 1 (S1) 0.044 0.045 0.044 0.044 0.042
    Support 2 (S2) 0.043 0.044 0.043 0.042
    Support 3 (S3) 0.041 0.043 0.041
    Support 4 (S4) 0.041